Category: Breaking

FDA Issues Emergency Use Authorization For Gilead’s Coronavirus Treatment Remdesivir

Remdesivir can now be administered intravenously by healthcare providers in the U.S. as it undergoes further study.

Stocks Had Their Best Month In 33 Years, But Here’s Why Experts Are Skeptical

There are reasons to doubt the stock market’s latest rally, experts say.

Sorry President Trump, But A Few Masks and A Commission Won’t Help Senior Living Facilities And Their Residents

President Trump has promised masks for nursing homes and a commission to study quality and safety in the wake of covid-19. Neither will be very helpfu.

Reopening States Before June Would Save Millions Of Jobs But Result In Hundreds Of Thousands More Coronavirus Deaths: Report

New findings from Penn Wharton show that reopening states in June would save jobs but put countless more lives at risk.

Cuomo Says New York Schools Will Remain Closed: ‘We’re Going To Err On The Side Of Caution’

A decision on summer school programs will be made by the end of May.

Stocks Fall, Dow Loses 400 Points After Trump Threatens New Tariffs On China

The market is down over 2% after wrapping up its best month in decades.

Apple’s Stock Falls After iPhone Sales Plunge Amid Coronavirus

Services revenue continued to show strong growth while iPhone sales slowed.

Trump Says Sweden ‘Paying Heavily’ For Failure To Lock Down As Deaths Toll Rise Over 2,500

Sweden has a COVID-19 mortality rate of 256 per million residents, three times higher than neighbor Denmark and six times Norway’s.

Russia’s Prime Minister Diagnosed With COVID-19 Amid Worsening Outbreak, Economic Outlook

“It just became known that the coronavirus tests I took came back positive.”

Mitch McConnell’s Idea To Let States Go Bankrupt Set Off A Debate That Engulfed Washington

Here’s a timeline of the ongoing debate over state and local government funding.